Envoy Medical Inc. (COCH)
Envoy Medical Statistics
Share Statistics
Envoy Medical has 21.29M shares outstanding. The number of shares has increased by 3.55% in one year.
| Shares Outstanding | 21.29M |
| Shares Change (YoY) | 3.55% |
| Shares Change (QoQ) | 3.29% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 10.07M |
| Failed to Deliver (FTD) Shares | 2.17K |
| FTD / Avg. Volume | 7.62% |
Short Selling Information
The latest short interest is 46.88K, so 0.22% of the outstanding shares have been sold short.
| Short Interest | 46.88K |
| Short % of Shares Out | 0.22% |
| Short % of Float | 0.49% |
| Short Ratio (days to cover) | 1.75 |
Valuation Ratios
The PE ratio is -0.76 and the forward PE ratio is -1.23. Envoy Medical's PEG ratio is -0.01.
| PE Ratio | -0.76 |
| Forward PE | -1.23 |
| PS Ratio | 71.93 |
| Forward PS | 1.2 |
| PB Ratio | -12.9 |
| P/FCF Ratio | -1.28 |
| PEG Ratio | -0.01 |
Enterprise Valuation
Envoy Medical Inc. has an Enterprise Value (EV) of 19.07M.
| EV / Earnings | -0.64 |
| EV / Sales | 60.36 |
| EV / EBITDA | -1.05 |
| EV / EBIT | -1.04 |
| EV / FCF | -1.07 |
Financial Position
The company has a current ratio of 1.03, with a Debt / Equity ratio of -0.32.
| Current Ratio | 1.03 |
| Quick Ratio | 0.82 |
| Debt / Equity | -0.32 |
| Total Debt / Capitalization | -46.83 |
| Cash Flow / Debt | -31.41 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 16.97% and return on capital (ROIC) is 1530.92%.
| Return on Equity (ROE) | 16.97% |
| Return on Assets (ROA) | -3.91% |
| Return on Capital (ROIC) | 1530.92% |
| Revenue Per Employee | $9,294.12 |
| Profits Per Employee | $-879,647.06 |
| Employee Count | 34 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 0.56 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -65.31% in the last 52 weeks. The beta is 2.38, so Envoy Medical's price volatility has been higher than the market average.
| Beta | 2.38 |
| 52-Week Price Change | -65.31% |
| 50-Day Moving Average | 1.46 |
| 200-Day Moving Average | 2.19 |
| Relative Strength Index (RSI) | 43.66 |
| Average Volume (20 Days) | 28.45K |
Income Statement
In the last 12 months, Envoy Medical had revenue of 316K and earned -29.91M in profits. Earnings per share was -2.38.
| Revenue | 316K |
| Gross Profit | -473K |
| Operating Income | -18.37M |
| Net Income | -29.91M |
| EBITDA | -18.24M |
| EBIT | -18.37M |
| Earnings Per Share (EPS) | -2.38 |
Balance Sheet
The company has 4.22M in cash and 562K in debt, giving a net cash position of 3.66M.
| Cash & Cash Equivalents | 4.22M |
| Total Debt | 562K |
| Net Cash | 3.66M |
| Retained Earnings | -257.24M |
| Total Assets | 9.4M |
| Working Capital | -1.94M |
Cash Flow
In the last 12 months, operating cash flow was -17.65M and capital expenditures -153K, giving a free cash flow of -17.81M.
| Operating Cash Flow | -17.65M |
| Capital Expenditures | -153K |
| Free Cash Flow | -17.81M |
| FCF Per Share | -1.42 |
Margins
Gross margin is -149.68%, with operating and profit margins of -5.81K% and -9.46K%.
| Gross Margin | -149.68% |
| Operating Margin | -5.81K% |
| Pretax Margin | -9.46K% |
| Profit Margin | -9.46K% |
| EBITDA Margin | -5.77K% |
| EBIT Margin | -5.81K% |
| FCF Margin | -5.64K% |
Dividends & Yields
COCH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -175% |
| FCF Yield | -61.49% |
Analyst Forecast
The average price target for COCH is $9, which is 561.8% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9 |
| Price Target Difference | 561.8% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
Scores
| Altman Z-Score | -48.83 |
| Piotroski F-Score | 0 |